TSRL
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
540 Avis Dr Ste A, Ann Arbor, Michigan, ...Phone Number
(734) 663-4233Website
www.tsrlinc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About TSRL
TSRL, Inc. is a preclinical contract research organization (CRO) based in Ann Arbor, Michigan, dedicated to assisting pharmaceutical, biotech, and academic teams in advancing early drug candidates. The company offers a range of integrated services including formulation development, bioanalysis, toxicology, and strategic consulting, all tailored to meet specific therapeutic needs and timelines. With a focus on reducing risk and generating high-quality data, TSRL combines scientific expertise with practical experience to support drug development. Their state-of-the-art facility features extensive wet lab space for comprehensive testing and research.Explore more
TSRL Org Chart
DR
Chief Operating Officer
SS
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TSRL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when TSRL launches new products
Check out if TSRL is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if TSRL had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at TSRL
Earning: See what the market has to say on TSRL recently announced quarterly report
TSRL, which may be a good buyer, showed buying intent in Masked Content Topic
Check if TSRL has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once TSRL has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined TSRL as Masked Content
Find 2 more new buyers
Compare Similar Companies to TSRL
Compare insights from companies similar to TSRL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TSRL is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TSRL is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TSRL.
TSRL financials insights
Gather financial insights about TSRL, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Debt
$185K
TSRL Tech Stack
A closer look at the technologies used by TSRL
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Clinical Operations, Operations
Funding
Project
Product Development, Clinical Operations, Operations
Funding
TSRL News & Media
PharmaTher and TSRL Enter into Co-Development Agreement For Microneedle Patch Delivery Technology for Psychedelics and Antivirals
TORONTO, June 01, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company and TSRL, Inc. (“TSRL”), a company focused on developing microneedle patches for the delivery of antivirals for the treatment of influenza, are pleased to announce that PharmaTher and TSRL (collectively the “Companies”) entered into a Co-Development Agreement to jointly develop a microneedle array patch with the aim to contrInfectious disease preclinical accelerator, TSRL, calls for proposals
Therapeutic Systems Research Laboratories (TSRL, Inc.) is now accepting proposals for its 2021 cohort of portfolio technologies. The preclinical accelerator is focused on advancing infectious disease assets.TSRL, Inc. awarded $3M NIH grant to continue development of microneedle patch for treatment of influenza
TSRL, Inc., announces the continued development of a transdermal delivery system of zanamivir (Relenza®), an inhalation drug product licensed for the treatment and prevention of influenza A & B. The project builds on an initial Phase I Small Business Innovation Research (SBIR) award of $600,000 to optimize microneedle formulations for painless administration of zanamivir through the skin. TSRL will receive approximately $3,000,000 over three years from a Phase II SBIR grant from the NationalTSRL Announces the Appointments of Martha Farmer and Stephen Munk to Board of Directors, and Gregory Amidon as Chairman of the Board
ANN ARBOR, Mich., Oct. 30, 2019 /PRNewswire/ -- TSRL, Inc., a preclinical accelerator, announces the appointments of Martha Farmer, PhD, and Stephen Munk, PhD to the Board of Directors, and Gregory Amidon, PhD, current board member, as Chairman. In addition, Dawn Reyna was appointed to...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding TSRL
Sign Up For FreeTo access detailed company insights
TSRL, Inc. is a preclinical contract research organization (CRO) based in Ann Arbor, Michigan, dedicated to assisting pharmaceutical, biotech, and academic teams in advancing early drug candidates. The company offers a range of integrated services including formulation development, bioanalysis, toxicology, and strategic consulting, all tailored to... Read More
